M&A Activity • Apr 12, 2021
M&A Activity
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 1092V
Asimilar Group PLC
12 April 2021
12 April 2021
Asimilar Group plc
('Asimilar' or the 'Company')
Update re: Dev Clever Holdings plc
Asimilar Group plc (AIM: ASLR), the AIM quoted investing company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT) notes the announcement made this morning by Dev Clever Holdings plc ("Dev Clever"), which is listed on the Standard List of the London Stock Exchange, regarding the proposed acquisition by Dev Clever of the entire issued share capital of Veative Labs Private Limited ("VLPL"), a wholly owned Indian subsidiary of Veative Labs Pte Ltd (Singapore) ("Veative"), subject among other things, to the publication of a prospectus.
Asimilar has an interest in 70 million ordinary shares in Dev Clever currently representing approximately 12.2 per cent. of Dev Clever's issued share capital. In addition to the 70 million ordinary shares, Asimilar retains a warrant to subscribe for 35 million new ordinary shares in Dev Clever at 25 pence per Dev Clever share.
The Dev Clever announcement can be viewed in full in the link below:
https://www.londonstockexchange.com/news-article/DEV/agreement-with-veative/14932290
-Ends-
Contacts
| Asimilar Group plc | |
| John Taylor, Non-Executive Chairman | via Buchanan |
| Cairn Financial Advisers LLP | |
| Sandy Jamieson / Liam Murray | Tel: +44 20 7213 0880 |
| Peterhouse Capital Limited | |
| Duncan Vasey / Lucy Williams | Tel: + 44 20 7220 9797 |
| Buchanan Communications Limited | |
| Richard Oldworth / Chris Lane | Tel: +44 (0) 20 7466 5000 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDDKBBNABKKPQD
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.